WHITELAB Trademark

Trademark Overview


On Wednesday, October 4, 2023, a trademark application was filed for WHITELAB with the United States Patent and Trademark Office. The USPTO has given the WHITELAB trademark a serial number of 98209041. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Thursday, June 13, 2024. This trademark is owned by Whitelab Genomics. The WHITELAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; Research services and development of new products for third parties; Industrial research in the field of biology; Industrial and pharmaceutical development in the field of human biology and diseases; scientific research in the field of genetics; Biological research; Technical research in the field of field of genetics, medical devices, genomic medicine, genetic engineering, synthetic biology, data science, artificial intelligence; Scientific and technical research and development in the field of genetics, medical devices, genetic engineering, synthetic biology, artificial intelligence; Research and development of medical devices; engineering services in the field of genetics; Scientific research services relating to the isolation and culture of human tissues and cells; scientific and medical research and development in the field of tissue manufacturing; research in the field of regenerative biotherapies, genomics; research and development of new pro...
whitelab

General Information


Serial Number98209041
Word MarkWHITELAB
Filing DateWednesday, October 4, 2023
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkWHITE LAB
Goods and ServicesScientific research and development; Research services and development of new products for third parties; Industrial research in the field of biology; Industrial and pharmaceutical development in the field of human biology and diseases; scientific research in the field of genetics; Biological research; Technical research in the field of field of genetics, medical devices, genomic medicine, genetic engineering, synthetic biology, data science, artificial intelligence; Scientific and technical research and development in the field of genetics, medical devices, genetic engineering, synthetic biology, artificial intelligence; Research and development of medical devices; engineering services in the field of genetics; Scientific research services relating to the isolation and culture of human tissues and cells; scientific and medical research and development in the field of tissue manufacturing; research in the field of regenerative biotherapies, genomics; research and development of new products in the field of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; scientific research and development for medical purposes; consulting services in scientific and industrial research; engineering in the medical field; design of diagnostic medical equipment and medical devices; computer-assisted diagnostic testing services for others for scientific research purposes; computer diagnostic services; design, development and maintenance of software and mobile applications for use in medical technologies; conversion of data or documents from physical to electronic media; Software as a Service featuring software for use in searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Computer Platform as a Service featuring software for use in searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Biopharmaceutical and pharmaceutical research services; Scientific research related to drugs, biopharmaceuticals and pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; Research and development in the field of diagnostic preparations; Research and development services in the field of medical diagnostic tools and software design; computer software design, development, installation, updating; electronic data storage in the field of DNA sequencing for diagnostic and therapeutic purposes; technical data analysis in the field of DNA sequencing for diagnostic and therapeutic purposes; IT consulting services relating to on-line searchable databases and algorithms for the management and delivery of scientific analysis results based on genomic data; rental and maintenance of software for searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals and medicines; rental of computer hardware; rental of scientific instruments; rental of laboratory apparatus and instruments; design and development of software for use in medical technologies; development and testing of methods, algorithms, and computer software in the field of multi-omics data including DNA and RNA sequencing; technical consulting services in the application and use of software; software engineering services for data processing programs; software engineering services; software as a service (SAAS) services featuring software platforms for use in artificial intelligence

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWhitelab Genomics
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCedex 91058
FR

Trademark Events


Event DateEvent Description
Friday, October 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, June 6, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, June 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 7, 2023NEW APPLICATION ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, June 6, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 13, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, June 13, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED